{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:22:07Z","timestamp":1784859727430,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12020-021-02744-8","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T16:03:28Z","timestamp":1620489808000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas"],"prefix":"10.1007","volume":"74","author":[{"given":"Kyla","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Pacione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Fatterpekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"12","key":"2744_CR1","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91(12), 4769\u20134775 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2744_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-444-59602-4.00013-7","volume":"124","author":"JA Romijn","year":"2014","unstructured":"J.A. Romijn, Hyperprolactinemia and prolactinoma. Handb. Clin. Neurol. 124, 185\u2013195 (2014)","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"2744_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0889-8529(05)70203-6","volume":"30","author":"ME Molitch","year":"2001","unstructured":"M.E. Molitch, Disorders of prolactin secretion. Endocrinol. Metab. Clin. North Am. 30(3), 585\u2013610 (2001)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"2744_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ecl.2014.11.003","volume":"44","author":"A Glezer","year":"2015","unstructured":"A. Glezer, M.D. Bronstein, Prolactinomas. Endocrinol. Metab. Clin. North Am. 44(1), 71\u201378 (2015)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"2","key":"2744_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11102-017-0854-2","volume":"21","author":"DL Penn","year":"2018","unstructured":"D.L. Penn, W.T. Burke, E.R. Laws, Management of non-functioning pituitary adenomas: surgery. Pituitary 21(2), 145\u2013153 (2018)","journal-title":"Pituitary"},{"issue":"2","key":"2744_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"S. Melmed, F.F. Casanueva, A.R. Hoffman et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(2), 273\u2013288 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2744_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000499694","volume":"109","author":"L Vilar","year":"2019","unstructured":"L. Vilar, C.F. Vilar, R. Lyra, M.D.C. Freitas, Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology 109(1), 7\u201319 (2019)","journal-title":"Neuroendocrinology"},{"key":"2744_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jcm8122203","volume":"8","author":"I Samperi","year":"2019","unstructured":"I. Samperi, K. Lithgow, N. Karavitaki, Hyperprolactinaemia. J. Clin. Med 8, 12 (2019)","journal-title":"J. Clin. Med"},{"issue":"2","key":"2744_CR9","first-page":"2010","volume":"15","author":"Y Huang","year":"2018","unstructured":"Y. Huang, C. Ding, F. Zhang, D. Xiao, L. Zhao, S. Wang, Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas. Oncol. Lett. 15(2), 2010\u20132016 (2018)","journal-title":"Oncol. Lett."},{"key":"2744_CR10","unstructured":"Burke WT, Penn DL, Castlen JP, et al. Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size. J Neurosurg. 1\u20138 (2019)"},{"issue":"3","key":"2744_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/14017438309099371","volume":"17","author":"L Kotsis","year":"1983","unstructured":"L. Kotsis, Z. Kris\u00e1r, J. Imre, M. Csikos, Complications of oesophagoplasty with isoperistaltic transverse colon. Scand. J. Thorac. Cardiovasc. Surg. 17(3), 317\u2013321 (1983)","journal-title":"Scand. J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"2744_CR12","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4), 610\u2013617 (1993). discussion 617\u2013618","journal-title":"Neurosurgery"},{"issue":"4","key":"2744_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"A.S. Micko, A. Wohrer, S. Wolfsberger, E. Knosp, Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg. 122(4), 803\u2013811 (2015)","journal-title":"J. Neurosurg."},{"issue":"10","key":"2744_CR14","first-page":"18990","volume":"8","author":"F Zhang","year":"2015","unstructured":"F. Zhang, Y. Huang, C. Ding, G. Huang, S. Wang, The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas. Int J. Clin. Exp. Med 8(10), 18990\u201318997 (2015)","journal-title":"Int J. Clin. Exp. Med"},{"issue":"5","key":"2744_CR15","first-page":"834","volume":"34","author":"MV Smith","year":"1994","unstructured":"M.V. Smith, E.R. Laws Jr, Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels. Neurosurgery 34(5), 834\u2013839 (1994). discussion 839","journal-title":"Neurosurgery"},{"issue":"4","key":"2744_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","volume":"65","author":"N Karavitaki","year":"2006","unstructured":"N. Karavitaki, G. Thanabalasingham, H.C. Shore et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin. Endocrinol. 65(4), 524\u2013529 (2006)","journal-title":"Clin. Endocrinol."},{"key":"2744_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-555","volume":"7","author":"T Kawaguchi","year":"2014","unstructured":"T. Kawaguchi, Y. Ogawa, T. Tominaga, Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging. BMC Res Notes 7, 555 (2014)","journal-title":"BMC Res Notes"},{"issue":"2","key":"2744_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1148\/radiol.2282020695","volume":"228","author":"A Hagiwara","year":"2003","unstructured":"A. Hagiwara, Y. Inoue, K. Wakasa, T. Haba, T. Tashiro, T. Miyamoto, Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation. Radiology 228(2), 533\u2013538 (2003)","journal-title":"Radiology"},{"issue":"2","key":"2744_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/cen.13064","volume":"85","author":"M Gruppetta","year":"2016","unstructured":"M. Gruppetta, J. Vassallo, Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study. Clin. Endocrinol. 85(2), 223\u2013231 (2016)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"2744_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11102-019-01001-6","volume":"23","author":"EV Varlamov","year":"2020","unstructured":"E.V. Varlamov, J.M. Hinojosa-Amaya, M. Fleseriu, Magnetic resonance imaging in the management of prolactinomas; a review of the evidence. Pituitary 23(1), 16\u201326 (2020)","journal-title":"Pituitary"},{"issue":"7","key":"2744_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00234-015-1519-3","volume":"57","author":"J Kreutz","year":"2015","unstructured":"J. Kreutz, L. Vroonen, F. Cattin et al. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference. Neuroradiology 57(7), 679\u2013684 (2015)","journal-title":"Neuroradiology"},{"issue":"4","key":"2744_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11102-018-0877-3","volume":"21","author":"SC Dogansen","year":"2018","unstructured":"S.C. Dogansen, G.Y. Yalin, S. Tanrikulu et al. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas. Pituitary 21(4), 347\u2013354 (2018)","journal-title":"Pituitary"},{"issue":"2","key":"2744_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12020-018-1765-3","volume":"63","author":"MC Burlacu","year":"2019","unstructured":"M.C. Burlacu, D. Maiter, T. Duprez, E. Delgrange, T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists. Endocrine 63(2), 323\u2013331 (2019)","journal-title":"Endocrine"},{"issue":"4","key":"2744_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"M.B.S. Lopes, The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 134(4), 521\u2013535 (2017)","journal-title":"Acta Neuropathol."}],"updated-by":[{"DOI":"10.1007\/s12020-021-02777-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000}},{"DOI":"10.1007\/s12020-021-02811-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000}}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02744-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T09:30:27Z","timestamp":1631611827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02744-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02744-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12020-021-02811-0","URL":"https:\/\/doi.org\/10.1007\/s12020-021-02811-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12020-021-02777-z","URL":"https:\/\/doi.org\/10.1007\/s12020-021-02777-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kyla Wright, Dr. Matthew Lee, Natalie Escobar, Dr. Donato Pacione, Dr. Girish Fatterpekar, and Dr. Matthew Young have nothing to disclose. Dr. Nidhi Agrawal is on the advisory board for Corcept Therapeutics and is a principal investigator for institution-directed research grants (Chiasm Acromegaly Registry).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board and carried out in accordance with the approved guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}